Based on the above results, cellular immunofluorescence (IF) staining was conducted to detect whether overexpression of SELENBP1 could change the localization of GPX1 from cytoplasm to nucleus in NSCLC cells. This evidence concerns the gene SELENBP1 and non-small cell lung carcinoma.